Tracking Semaglutide: Dose Titration and Side Effects

Semaglutide is unusual in the peptide world because it has gone fully mainstream as a prescription medication. Whether someone is using it under medical supervision or as a self-experimenter, the tracking problem is the same: dose changes slowly over months, side effects shift with each step, and outcomes are easy to misattribute.

The titration shape

Most semaglutide protocols follow a stepped titration:

• Week 1–4: starter dose
• Week 5–8: step 2
• Week 9–12: step 3
• Week 13+: target dose

The exact mg per step varies. The structure is consistent: change one variable, hold for a few weeks, evaluate, then change again.

What to track daily

A short daily log captures the most signal:

• Appetite score (1–10) — how easy is it to skip a meal?
• Nausea score (0–10)
• Energy (1–10)
• GI symptoms — bloating, constipation, reflux
• Hydration — total fluid intake in ml or cups

You do not need lab-grade precision. You need consistency. Same scale, every day.

What to track weekly

• Weight — same scale, same time, same clothing
• Waist circumference — one of the better proxies for body composition change
• Body photos — front, side, back; same lighting

Daily weigh-ins are noisy. Weekly weigh-ins are a trend.

What to track at each dose increase

This is where most logs fall apart. People remember to log doses and forget to log step changes.

At every titration step:

• The new dose
• Date of first administration
• Side effects for the first 7 days after the step
• Any required dose hold (some people hold an extra week before stepping up)

Peptide IA treats a titration as a multi-step protocol so the steps appear on the same timeline as your doses.

Side effects worth logging in detail

• Nausea — often peaks 1–3 days after a dose increase
• GI motility changes — constipation is more common than diarrhea
• Heartburn / reflux — slowed gastric emptying is the mechanism
• Injection site reactions — redness, itching
• Mood changes — appetite-suppressing effects sometimes correlate

If a side effect lasts beyond ~2 weeks at a given step, that is a signal to discuss holding or reducing the dose with your physician.

Outcome metrics

Beyond weight, the questions worth answering:

• Energy at fixed caloric intake — are you tired or fine?
• Workout performance — strength, endurance, recovery
• Bloodwork — see the separate post on bloodwork during cycles

The "is this working" question

Semaglutide effects compound over months, not days. If you weigh yourself daily and panic about a 0.5 kg bump, you are reading noise. Log weekly. Look at 4-week rolling averages. Only judge effectiveness on at least 8 weeks of data.

Holds and pauses

Tracking gets confusing during pauses (travel, side-effect holds, supply gaps). Mark these explicitly. A 2-week pause looks like a plateau if you do not annotate it. Peptide IA treats a hold as a first-class event so the timeline stays honest.

Coming off

Most users see appetite return over weeks after stopping. Continue logging during the taper and for at least 8 weeks after the final dose — that is where the long-term picture lives.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.